Split History
ETFs Holding INCY »    INCY Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Incyte is a biopharmaceutical company focused on developing and commercializing proprietary therapeutics for oncology. Co.'s commercialized product is JAKAFI® (ruxolitinib), an oral JAK1 and JAK2 inhibitors, for the treatment of patients with intermediate or high-risk myelofibrosis. Co. also has a development pipeline that consists of the following compounds: ruxolitinib to treat breast cancer; ruxolitinib to treat pancreatic cancer; ruxolitinib to treat non-small cell lung cancer; INCB39110 to treat non-small cell lung cancer and advanced malignancies, INCB52793 to treat advanced malignancies; INCB40093 to treat B-lymphoid Malignancies and INCB50465 to treat hematology/oncology. According to our INCY split history records, Incyte has had 2 splits.
INCY split history picture
Incyte (INCY) has 2 splits in our INCY split history database. The first split for INCY took place on November 10, 1997. This was a 2 for 1 split, meaning for each share of INCY owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. INCY's second split took place on September 01, 2000. This was a 2 for 1 split, meaning for each share of INCY owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split.

When a company such as Incyte splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. Looking at the INCY split history from start to finish, an original position size of 1000 shares would have turned into 4000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Incyte shares, starting with a $10,000 purchase of INCY, presented on a split-history-adjusted basis factoring in the complete INCY split history. INCY split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/29/2006
End date: 06/28/2016
Start price/share: $4.35
End price/share: $76.58
Dividends collected/share: $0.00
Total return: 1,660.46%
Average Annual Total Return: 33.20%
Starting investment: $10,000.00
Ending investment: $176,085.85
Years: 10.01
Date Ratio
11/10/19972 for 1
09/01/20002 for 1
INCY is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

INFI Split History
INO Split History
INSY Split History
IVC Split History
JNJ Split History
JUNO Split History
KBIO Split History
KOOL Split History
LCAV Split History
LCI Split History

China Ceramics Co., Ltd. (CCCL)
iBonds Mar 2023 Term Corporate ETF (IBDD)
iBonds Mar 2020 Term Corporate ETF (IBDC)
iBonds Mar 2018 Term Corporate ETF (IBDB)
iBonds Mar 2023 Term Corporate ex-Financials ETF (IBCE)
iBonds Mar 2020 Term Corporate ex-Financials ETF (IBCD)
iBonds Mar 2018 Term Corporate ex-Financials ETF (IBCC)
iShares Core 1-5 Year USD Bond ETF (ISTB)
iShares Core Total USD Bond Market ETF (IUSB)
iShares Core U.S. Value ETF (IUSV)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

INCY Insider Buying

INCY Split History | www.SplitHistory.com | Copyright © 2013 - 2016, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.